|
Division
of Metabolic and Endocrine Drug Products
Areas of Responsibility
The Division of Metabolic and Endocrine Drug
Products reviews Investigational New Drug applications and New Drug Applications in the
following drug and disease areas:
- Adrenal dysfunction
- Anabolic drugs
- Bone metabolism disorders
- Diabetes
- Growth and development disorders
- Lipid lowering agents
- Metabolic disorders
- Obesity
- Osteoporosis
- Thyroid dysfunction
- Vasopressins
- Vitamins, Nutrients and Amino acids
The Division facilitates the development of safe and
effective endocrine and metabolic drug products by working with sponsors throughout the new drug development process.
Sponsors are encouraged to contact the division at any stage of the process.
 Back
to Top 
DMEDP Home
Date created: October 28, 2004 |
